# Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

> **NCT01161160** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 209 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK Biologicals' GSK2340274A (two different formulations)
- **BIOLOGICAL:** GSK Biologicals' - GSK2340272A

## Key facts

- **NCT ID:** NCT01161160
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-01
- **Primary completion:** 2010-08-23
- **Final completion:** 2011-01-31
- **Target enrollment:** 209 (ACTUAL)
- **Last updated:** 2018-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01161160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01161160, "Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01161160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*